Document is current
Any future updates will be listed below
-
Authors
Strobl, Johanna https://orcid.org/0000-0003-3606-2185
Kleissl, Lisa https://orcid.org/0000-0001-8011-796X
Eder, Julia https://orcid.org/0000-0001-5555-8536
Connolly, Sally https://orcid.org/0000-0001-5180-5384
Frey, Tobias https://orcid.org/0000-0002-6274-9864
Gail, Laura Marie https://orcid.org/0000-0002-2525-9399
Kopf, Aglaja https://orcid.org/0000-0002-2187-6656
Weninger, Sophie
Markowicz, Mateusz
Bartíková, Pavlína https://orcid.org/0000-0003-3979-2001
Freystätter, Christian
Schmetterer, Klaus https://orcid.org/0000-0001-9328-4871
Strobl, Herbert https://orcid.org/0000-0002-8070-4977
Stockinger, Hannes https://orcid.org/0000-0001-6404-4430
Wijnveld, Michiel https://orcid.org/0000-0003-4559-5960
Stary, Georg https://orcid.org/0000-0003-1746-4250
-
Funding
Funding for this research was provided by:
Austrian Science Fund (PAT 8019123)
- License Information
-
More Information
Article History
Received: 18 October 2024
Accepted: 13 November 2025
First Online: 28 November 2025
Competing interests
: J.S. discloses serving as consultant for Pfizer (C4601003 pfVLA15a Adjudication Committee). M.M. is an unpaid member of the Executive Committee of ESGBOR, the ESCMID Study Group for Lyme Borreliosis and discloses serving as consultant for Pfizer unrelated to this study. The other authors have declared that no conflict of interest exists.
